New inhaled treatment could slow ALS progression
Disease control
Recruiting now
This study is testing whether an inhaled medication called PHENOGENE-1A (cromolyn) can help slow the progression of ALS when added to standard treatment. Researchers will enroll 105 adults with mild to moderate ALS to receive either the study drug or a placebo for 24 weeks. The m…
Phase: PHASE2 • Sponsor: PhenoNet, Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC